Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,99 USD | +7,57% | +23,60% | -33,89% |
Attività
Numero di dipendenti: 14
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Vision Performance and Health
100,0
%
| 40 | 100,0 % | 19 | 100,0 % | -52,20% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 40 | 100,0 % | 19 | 100,0 % | -52,20% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
George Magrath
CEO | Chief Executive Officer | 40 | 01/11 |
Nirav Jhaveri
DFI | Director of Finance/CFO | 46 | 14/02 |
Barbara Withers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Mitchell Brigell
CTO | Chief Tech/Sci/R&D Officer | - | - |
Joseph Schachle
COO | Chief Operating Officer | 59 | 27/11 |
Richard Rodgers
BRD | Director/Board Member | 57 | 01/11/20 |
Ronil Patel
PRN | Corporate Officer/Principal | - | 01/07/21 |
Erik Sims
PRN | Corporate Officer/Principal | - | 01/04/21 |
Drey Coleman
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 68 | 01/01/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 01/11/20 |
James Manuso
BRD | Director/Board Member | 75 | 01/01/19 |
Susan Benton
BRD | Director/Board Member | 59 | 01/11/20 |
Cam Gallagher
CHM | Chairman | 54 | 01/01/19 |
Sean Ainsworth
BRD | Director/Board Member | 56 | 01/04/18 |
George Magrath
CEO | Chief Executive Officer | 40 | 01/11 |
Jay Pepose
BRD | Director/Board Member | 69 | 07/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 24 813 370 | 23 942 205 ( 96,49 %) | 0 | 96,49 % |
Coordinate società
Ocuphire Pharma, Inc.
37000 Grand River Avenue Suite 120
48335, Farmington Hills
+
http://www.ocuphire.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-33,89% | 50,96 Mln | |
+26,08% | 662 Mrd | |
+21,85% | 546 Mrd | |
-4,77% | 359 Mrd | |
+16,97% | 323 Mrd | |
+5,69% | 290 Mrd | |
+13,68% | 234 Mrd | |
+3,65% | 198 Mrd | |
-11,12% | 194 Mrd | |
+8,08% | 167 Mrd |
- Borsa valori
- Azioni
- Azione OCUP
- Società Ocuphire Pharma, Inc.